Last reviewed · How we verify

NCT04532190: FAST-ADHD

Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder

Recruiting now NA Last updated 25 November 2025
What this trial tests

NA trial testing rTMS in Attention-Deficit/Hyperactivity Disorder (ADHD) in 30 participants. Currently enrolling.

Timeline
1 March 2026
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorUniversity of Calgary
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 March 2026
Primary completion31 December 2027
Estimated completion31 December 2027
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Calgary

Who can join

Adults 9 to 15, any sex, with Attention-Deficit/Hyperactivity Disorder (ADHD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of rTMS

Trials testing the same drug.

Other University of Calgary trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04532190.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing